Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Health Insurance Innovations Inc    HIIQ

HEALTH INSURANCE INNOVATIONS INC (HIIQ)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Health Insurance Innovations, Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/12/2017 | 12:32am CEST

Levi & Korsinsky announces it has commenced an investigation of Health Insurance Innovations, Inc. (“Health Insurance” or the “Company”) (NASDAQ:HIIQ) concerning possible violations of federal securities laws.

On September 11, 2017, an article was published on Seeking Alpha alleging, among other allegations, that: (1) in June 2017, one of the Company’s key license applications was rejected after regulators uncovered undisclosed legal actions against Company insiders; and (2) the Company privately warned a Florida regulator that a rejection of its license application could create a “domino effect” whereby licensing denials would spread to the other states. Following this news, shares of Health Insurance fell more than 18% to close at $23.35 per share on September 11, 2017. To obtain additional information, go to:

http://www.zlkdocs.com/HIIQ-Info-Request-Form-6098

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HEALTH INSURANCE INNOVATIO
06/08HEALTH INSURANCE INNOVATIONS, INC. : Termination of a Material Definitive Agreem..
AQ
05/24HEALTH INSURANCE INNOVATIONS : College Students and Grads Need Affordable Health..
PR
05/21HEALTH INSURANCE INNOVATIONS, INC. : Submission of Matters to a Vote of Security..
AQ
05/16Health Insurance Innovations, Inc. to Present at B. Riley FBR 19th Annual Ins..
GL
05/16HEALTH INSURANCE INNOVATIONS INC : Free Stock Performance Review on UnitedHealth..
AC
05/15Health Insurance Innovations Presents at the UBS Global Healthcare Conference..
GL
05/11ROBBINS ARROYO LLP : Health Insurance Innovations, Inc. (HIIQ) Misled Shareholde..
BU
05/09AGILEHEALTHINSURANCE REPORT : Price Advantage of Short-Term Health Insurance Ove..
PR
05/03HEALTH INSURANCE INNOVATIONS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL..
AQ
05/03HEALTH INSURANCE INNOVATIONS, INC. : Results of Operations and Financial Conditi..
AQ
More news
News from SeekingAlpha
07/10Health Insurance Innovations Set To Excel On Changes To Healthcare Policy 
06/08Health Insurance Innovations founder out 
05/14P2 Capital reports 7.5% stake in Health Insurance Innovations 
05/03Health Insurance Innovations' (HIIQ) CEO Gavin Southwell on Q1 2018 Results -.. 
05/02Health Insurance Innovations beats by $0.02, misses on revenue 
Financials ($)
Sales 2018 295 M
EBIT 2018 49,4 M
Net income 2018 24,6 M
Debt 2018 -
Yield 2018 -
P/E ratio 2018 18,91
P/E ratio 2019 22,59
Capi. / Sales 2018 1,84x
Capi. / Sales 2019 1,62x
Capitalization 542 M
Chart HEALTH INSURANCE INNOVATIO
Duration : Period :
Health Insurance Innovatio Technical Analysis Chart | HIIQ | US42225K1060 | 4-Traders
Technical analysis trends HEALTH INSURANCE INNOVATIO
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 48,4 $
Spread / Average Target 49%
EPS Revisions
Managers
NameTitle
Gavin C. Southwell President, Chief Executive Officer & Director
Paul G. Gabos Non-Executive Chairman
Michael D. Hershberger Chief Financial Officer, Secretary & Treasurer
Sheldon X. Wang Chief Technology Officer & Director
Michael W. Kosloske Director
Sector and Competitors
1st jan.Capitalization (M$)
HEALTH INSURANCE INNOVATIONS INC30.36%542
MEDIBANK PRIVATE LTD-6.99%6 288
SUL AMERICA SA18.57%2 211
BUPA ARABIA FOR COOPERATIVE INSU CO SJSC--.--%1 958
NIB HOLDINGS LIMITED-17.75%1 887
TRUPANION INC57.02%1 489